Bayer Rolls Up Its Sleeves But Turnaround Will Take Time

Bayer board of management at the 2025 annual press conference (l-r): Wolfgang Nickl, Bill Anderson, Heike Prinz, Rodrigo Santos, Julio Triana and Stefan Oelrich
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Earnings

More from Therapy Areas